| Net income | -3.76M |
| Depreciation and amortization | 13.83M |
| Deferred income tax | -2.69M |
| Stock-based compensation expense, net | 972K |
| Accounts receivable, net | -3.83M |
| Inventory, net | -3.44M |
| Accounts payable | 6.11M |
| Accrued employment costs | -29K |
| Income taxes | 269K |
| Other, net | 642K |
| Net cash used in operating activities | |
| Capital expenditures | -3.12M |
| Proceeds from sale of fixed assets | 1.57M |
| Net cash used in investing activities | |
| Long-term debt repayments | |
| Proceeds from the issuance of Common Stock | 571K |
| State grant funding the purchase of new equipment | |
| Tax benefit from stock-based payment arrangements | |
| Net cash used in financing activities | |
| Net decrease in cash and cash equivalents | 265K |
| Cash and cash equivalents at beginning of period | 112K |
| Cash and cash equivalents at end of period | 377K |